Status:
COMPLETED
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Cancer
Neoplasms
Eligibility:
All Genders
12-120 years
Brief Summary
Background: Cancer pain can have a very negative effect on people s daily lives. Researchers want to use machine learning to detect facial expressions and voice signals. They want to help people with...
Detailed Description
Background: * Pain related to cancer/tumors can be widespread, wield debilitating effects on daily life, and interfere with otherwise positive outcomes from targeted treatment. * The underpinnings of...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Ability of subject to understand and willingness to sign a written informed consent document.
- Adults and children (including NIH staff) aged \>= 12 years.
- Participants with diagnosis of a cancer or tumor
- Participant must be receiving either standard of care or investigational cancer/tumor treatment either at NIH or with a community physician.
- Must have access to a smart phone (iPhone or Android) with either a data plan and/or access to wireless internet (wifi) or a computer with a camera and microphone and access to internet and must willing to use their device and assume any associated charges from
- service providers.
- EXCLUSION CRITERIA:
- Participants with progressive brain tumors or metastasis. Participants with treated brain metastasis or primary brain tumor are eligible if there is no evidence of progression for at least 4 weeks after CNS directed treatment and there is no impact on voice or facial muscle movements.
- Participants with Parkinson s disease.
- Known current alcohol or drug abuse.
- Any psychiatric condition that would prohibit the understanding or rendering of informed consent.
- Non-English speaking subjects.
Exclusion
Key Trial Info
Start Date :
October 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 27 2024
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT04442425
Start Date
October 27 2020
End Date
March 27 2024
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892